From e25e5d21adfaf8a8d06b2032fd8b648d1b58f664 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Wed, 17 Jan 2024 11:30:09 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/Albendazol.md | 1 + pages/STOP2030___Viaje a Ghana 2023.md | 6 +++--- 2 files changed, 4 insertions(+), 3 deletions(-) create mode 100644 pages/Albendazol.md diff --git a/pages/Albendazol.md b/pages/Albendazol.md new file mode 100644 index 00000000..50e5cf95 --- /dev/null +++ b/pages/Albendazol.md @@ -0,0 +1 @@ +alias:: albendazole diff --git a/pages/STOP2030___Viaje a Ghana 2023.md b/pages/STOP2030___Viaje a Ghana 2023.md index 6e7150d3..593215c9 100644 --- a/pages/STOP2030___Viaje a Ghana 2023.md +++ b/pages/STOP2030___Viaje a Ghana 2023.md @@ -31,9 +31,9 @@ date:: [[2023/12]] - Reference lab - Samples should be run on site (Kato Katz in the schools) and others in-country (ELISA dried blood spots for [[Strongyloides]]), with a lab in Accra still to be identified. - ##### Communication & Social mobilization - NTD Programme/ [[GHS/RDD]]/Health Promotion/Mundo Sano - - Frame messaging on why doing clinical trial as based on [[Trichuris trichiura]] burden – evidence for clinical trial most clear as albendazole is less effective and we have decent burden data; Reinforce messaging that will be a clinical trial, building on and using MDA architecture as much as possible - - GHS to review external communications plan – Tuesday 19th - - All/Mundo Sano facilitate + - Frame messaging on why doing clinical trial as based on [[Trichuris trichiura]] burden – evidence for clinical trial most clear as [[albendazole]] is less effective and we have decent burden data; Reinforce messaging that it will be a clinical trial, building on and using MDA architecture as much as possible + - [[GHS]] to review external communications plan – Tuesday 19th + - All/ [[Mundo Sano]] facilitate - Circulate and review materials from past MDA and/or relevant trials from communications/social mobilization (GHS has already circulated) - Align on targeted changes for Ghana and for Kenya (meeting with Kenya scheduled for December 19th with the Comms team) - Consider how to reflect non-STH diseases also addressed by the FDC (e.g. Onchocercosis, Limphatic Filariasis, Scabies). This was consulted with the Comms team an we are not sure it is a good idea. Perhaps we can think about doing posters and material to be left to the sites after the project, but not during the study, to avoid confussion.